OG biotech 23andMe is heading to bankruptcy, so what does that mean for the DNA of 14 million users?
Now the company's on the brink of bankruptcy, it's raised concerns about what will happen to the genetic data it has in its ...
Stock splits are typically viewed as bullish indicators that a company sees more growth is on the horizon. Although nothing ...
Me helped usher in the era of consumer DNA test kits nearly two decades ago, but has more recently faced a series of setbacks ...
The company’s valuation had dropped from $6 billion in 2021, to under $150 million after going public and when CEO Anne Wojcicki pushed for a plan to buy it and take it private, the board rejected her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback